BIOA
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against BioAge Labs Inc., (BIOA)
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has...
Read moreDetails
BIOA INVESTOR ALERT: Edelson Lechtzin LLP Urges BioAge Labs, Inc. (NASDAQ: BIOA) Shareholders to Consult Legal Counsel About the Impending Lead Plaintiff Deadline in the Securities Fraud Class Action
NEWTOWN, Pa. , Jan. 8, 2025 /PRNewswire/ -- Edelson Lechtzin LLP, a leading class action law firm, is investigating securities...
Read moreDetails
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law...
Read moreDetails
BIOAGE LABS, INC. (NASDAQ: BIOA) INVESTOR ALERT: Investors With Large Losses in BioAge Labs, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class...
Read moreDetails
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BioAge Labs, Inc. – BIOA
NEW YORK , Jan. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BioAge Labs,...
Read moreDetails
BIOA INVESTOR ALERT: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO , Jan. 8, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that...
Read moreDetails
BIOAGE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against BioAge Labs, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm,...
Read moreDetails
BioAge Labs (BIOA) Faces Securities Class Action On Behalf Of IPO Investors After Discontinuing Weight-Loss Drug Trial– Hagens Berman
SAN FRANCISCO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is...
Read moreDetails
BIOA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead the BioAge Labs Class Action Lawsuit
SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of...
Read moreDetails
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of BioAge Labs, Inc. Stock and Sets a Lead Plaintiff Deadline of March 10, 2025
NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To:...
Read moreDetails